SUPPLIERS
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
Click Us!
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 41031
Submission : 2025-03-23
Status : Active
Type : IV
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23692
Submission : 2010-04-06
Status : Active
Type : IV
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23692
Submission : 2010-04-06
Status : Active
Type : IV
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 41031
Submission : 2025-03-23
Status : Active
Type : IV
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]LISTED SUPPLIERS
FINISHED DOSAGE FORMULATIONS
FDF DOSSIERS SUPPLIERS
Drug : TOBRAMYCIN AND DEXAMETHASONE
Dosage Form : SUSPENSION/DROPS; OPHTHALMIC
Application Number : 64134
Country : US
Patented : No
Drug : TOBRAMYCIN
Dosage Form : SOLUTION/DROPS; OPHTHALMIC
Application Number : 64052
Country : US
Patented : No
Drug : AKTOB
Dosage Form : SOLUTION/DROPS; OPHTHALMIC
Application Number : 64096
Country : US
Patented : No
Drug : TOBRADEX ST
Dosage Form : SUSPENSION/DROPS; OPHTHALMIC
Application Number : 50818
Country : US
Patented : Yes
Drug : NEVANAC
Dosage Form : SUSPENSION/DROPS; OPHTHALMIC
Application Number : 21862
Country : US
Patented : Yes
Drug : ALOMIDE
Dosage Form : SOLUTION/DROPS; OPHTHALMIC
Application Number : 20191
Country : US
Patented : No
Drug : TOBREX
Dosage Form : SOLUTION/DROPS; OPHTHALMIC
Application Number : 50541
Country : US
Patented : No
Drug : TOBREX
Dosage Form : SOLUTION/DROPS; OPHTHALMIC
Application Number : 62535
Country : US
Patented : No
Drug : GENTAMICIN SULFATE
Dosage Form : SOLUTION/DROPS; OPHTHALMIC
Application Number : 62196
Country : US
Patented : No
Drug : TOBRADEX
Dosage Form : SUSPENSION/DROPS; OPHTHALMIC
Application Number : 50592
Country : US
Patented : No
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EXCIPIENTS BY APPLICATIONS
Thickeners And Stabilizers
Gangwal Healthcare is powered by innovation, driving health, wellness & healing.
Dosage Form : Cream / Lotion / Ointment, Syrup, Injectable / Parenteral
Grade : Oral, Ophthalmic, Injectable...
Category : Thickeners and Stabilizers
Application : Thickeners and Stabilizers
Excipient Details : Tyloxapol is used as a solubilizing, emulsifying and stabilizing agent in nebulizers, eye drops, injectables, oral syrups and topical dosage forms.
Pharmacopoeia Ref : USP-NF, DMF, EXCiPAT, KOSHER, ...
Technical Specs : NA
Ingredient(s) : Tyloxapol
Solubilizers
Gangwal Healthcare is powered by innovation, driving health, wellness & healing.
Dosage Form : Cream / Lotion / Ointment, Injectable / Parenteral, Ophthalmic Solution
Grade : Oral, Ophthalmic, Injectable...
Category : Solubilizers
Application : Solubilizers
Excipient Details : Tyloxapol is used as a solubilizing, emulsifying and stabilizing agent in nebulizers, eye drops, injectables, oral syrups and topical dosage forms.
Pharmacopoeia Ref : USP-NF, DMF, EXCiPAT, KOSHER, ...
Technical Specs : NA
Ingredient(s) : Tyloxapol
Application : Solubilizers
Excipient Details : Tyloxapol excipient is used as an solubilizing agent in the ophthalmic products.
Digital Content
DATA COMPILATION #PharmaFlow
MARKET PLACE
EXCIPIENTS
Reply
07 May 2022
Reply
16 Jan 2021
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Comment (3)
